Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15426 - 15450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	PTGS2	5743	upregulated	Bortezomib results in increased expression of PTGS2 mRNA	1q31.1	A21435
Bortezomib	Approved Investigational	PTHLH	5744	downregulated	Bortezomib results in decreased expression of PTHLH mRNA	12p11.22	A21450
Bortezomib	Approved Investigational	PTP4A3	11156	downregulated	Bortezomib results in decreased expression of PTP4A3 mRNA	8q24.3	A21434
Bortezomib	Approved Investigational	PTPN11	5781	downregulated	Bortezomib results in decreased expression of PTPN11 mRNA	12q24.13	A21434
Bortezomib	Approved Investigational	PTPN6	5777	downregulated	Bortezomib results in decreased expression of PTPN6 mRNA	12p13.31	A21437
Bortezomib	Approved Investigational	PTX3	5806	downregulated	Bortezomib results in decreased expression of PTX3 mRNA	3q25.32	A20714
Bortezomib	Approved Investigational	R3HDM4	91300	downregulated	Bortezomib results in decreased expression of R3HDM4 mRNA	19p13.3	A21434
Bortezomib	Approved Investigational	RAB5A	5868	downregulated	Bortezomib results in decreased expression of RAB5A mRNA	3p24.3	A21434
Bortezomib	Approved Investigational	RAB8B	51762	downregulated	Bortezomib results in decreased expression of RAB8B mRNA	15q22.2	A21434
Bortezomib	Approved Investigational	RAC2	5880	downregulated	Bortezomib results in decreased expression of RAC2 mRNA	22q13.1	A21434
Bortezomib	Approved Investigational	RAD51	5888	downregulated	Bortezomib results in decreased expression of RAD51 mRNA	15q15.1	A21448
Bortezomib	Approved Investigational	RALA	5898	upregulated	Bortezomib results in increased expression of RALA mRNA	7p14.1	A21434
Bortezomib	Approved Investigational	RAPGEF1	2889	downregulated	Bortezomib results in decreased expression of RAPGEF1 mRNA	9q34.13	A21434
Bortezomib	Approved Investigational	RAPH1	65059	upregulated	Bortezomib results in increased expression of RAPH1 mRNA	2q33.2	A21434
Bortezomib	Approved Investigational	RB1CC1	9821	upregulated	Bortezomib results in increased expression of RB1CC1 mRNA	8q11.23	A21434
Bortezomib	Approved Investigational	RCAN3	11123	downregulated	Bortezomib results in decreased expression of RCAN3 mRNA	1p36.11	A21434
Bortezomib	Approved Investigational	RDH11	51109	upregulated	Bortezomib results in increased expression of RDH11 mRNA	14q24.1	A21434
Bortezomib	Approved Investigational	RDH13	112724	upregulated	Bortezomib results in increased expression of RDH13 mRNA	19q13.42	A21434
Bortezomib	Approved Investigational	RECQL4	9401	upregulated	Bortezomib results in increased expression of RECQL4 mRNA	8q24.3	A21434
Bortezomib	Approved Investigational	RELA	5970	downregulated	Bortezomib results in decreased expression of RELA mRNA	11q13.1	A21434
Bortezomib	Approved Investigational	RFFL	117584	upregulated	Bortezomib results in increased expression of RFFL mRNA	17q12	A21434
Bortezomib	Approved Investigational	RHOT2	89941	downregulated	Bortezomib results in decreased expression of RHOT2 mRNA	16p13.3	A21434
Bortezomib	Approved Investigational	RIPK1	8737	downregulated	Bortezomib results in decreased expression of RIPK1 mRNA	6p25.2	A20714
Bortezomib	Approved Investigational	RIT1	6016	upregulated	Bortezomib results in increased expression of RIT1 mRNA	1q22	A21434
Bortezomib	Approved Investigational	RND3	390	upregulated	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of RND3 mRNA	2q23.3	A21436

Displaying entries 15426 - 15450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability